Background strain: | cMJ030 | Click here to order this strain from the Chlamydomonas Resource Center. The background strain comes free with every order. |
Transformation condition: | RY0402 | |
Antibiotic resistance: | resistant to paromomycin |
Insertion junctions | |||||
Insertion junction | Locus systematic id | Locus common name | Defline | Feature | Confidence (%) |
---|---|---|---|---|---|
LMJ.RY0402.132774_1 | Cre02.g078966 | FTSH9,FHL5 | FtsH-like ATPase/metalloprotease; (1 of 1) PTHR23076//PTHR23076:SF70 - METALLOPROTEASE M41 FTSH // ATP-DEPENDENT ZINC METALLOPROTEASE FTSH 7, CHLOROPLASTIC-RELATED | intron | 58 |
LMJ.RY0402.132774_2 | Cre09.g387400 | POLZ1 | DNA polymerase zeta; (1 of 1) K02350 - DNA polymerase zeta (POLZ1, rev3) | CDS | 73 |
If you use this mutant for your work, please cite: Li et al. 2019 Nature Genetics.
This mutant exhibited a phenotype under the following conditions:
Bleomycin sulfate, screen 1 of 2 (~20.0% growth defect) |
Bleomycin sulfate, screen 2 of 2 (~20.0% growth defect) |
Cisplatin, screen 2 of 4 (~50.0% growth defect) |
Cisplatin, screen 3 of 4 (~80.0% growth defect) |
Cisplatin, screen 4 of 4 (~60.0% growth defect) |
Methyl methanesulfonate, screen 4 of 4 (~10.0% growth defect) |
Mitomycin C, screen 2 of 4 (No growth detected) |
Mitomycin C, screen 3 of 4 (~80.0% growth defect) |
Mitomycin C, screen 4 of 4 (No growth detected) |
UV radiation, screen 2 of 2 (~80.0% growth defect) |
Zeocin, screen 2 of 5 (~30.0% growth defect) |
Zeocin, screen 3 of 5 (~20.0% growth defect) |
Zeocin, screen 4 of 5 (~40.0% growth defect) |
Zeocin, screen 5 of 5 (~20.0% growth defect) |
Note: Not all phenotypes can be confidently associated with a specific gene or insertion; phenotypes can be caused by unmapped second-site mutations. Please see the gene pages for statistically significant gene-phenotype links. These data are from a pooled phenotyping experiment.
If you reference the phenotypic data above in a manuscript, please cite: Fauser et al. 2022 Nature Genetics.